Aquestive Therapeutics, Inc. Common Stock
Symbol: AQST (NASDAQ)
7.01
▼ (-6.41%) -0.480
Company Description:
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Key Stats
- Today's Open: $6.989
- Today's High: $7.05
- Today's Low: $6.985
- Today's Volume: 19.50K
- Yesterday Close: $7.49
- Yesterday High: $7.55
- Yesterday Low: $7.17
- Yesterday Volume: 3.21M
- Last Min Volume: 201
- Last Min High: $7.01
- Last Min Low: $7.01
- Last Min VWAP: $7.01
Company Profile
- Name: Aquestive Therapeutics, Inc. Common Stock
- Website: https://www.aquestive.com
- Listed Date: 2018-07-25
- Location: WARREN, NJ
- Market Status: Active
- CIK Number: 0001398733
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $906.09M
- Round Lot: 100
- Outstanding Shares: 120.97M
- Asset Type: CS
RECENT FILINGS FOR AQST
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G/A | View |
| 2025-10-17 | 4 | View |
| 2025-10-17 | 4 | View |
| 2025-10-17 | 4 | View |
| 2025-10-15 | 144 | View |
| 2025-10-15 | 144 | View |
| 2025-10-15 | 144 | View |
| 2025-10-08 | 8-K | View |
| 2025-10-01 | 8-K | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 144 | View |
| 2025-09-26 | 144 | View |
| 2025-09-22 | 4 | View |
| 2025-09-19 | 144 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 4 | View |
| 2025-09-08 | 8-K | View |
| 2025-09-05 | 144 | View |
| 2025-09-04 | 144 | View |
Latest News on AQST